Organization
JPM van Stralen Medicine Professional
2 clinical trials
Clinical trial
A Multi-Center, Open Label, Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With Attention Deficit Hyperactivity Disorder and Autism Spectrum DisorderStatus: Completed, Estimated PCD: 2023-03-31
Clinical trial
A Phase IV, Dose Optimized, Open Label, Evaluation of the Effect Foquest® (Methylphenidate HCl Controlled Release) on Sleep in Children Aged 6-12 With Attention Deficit Hyperactivity DisorderStatus: Active (not recruiting), Estimated PCD: 2023-12-31